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Abstract 
Hospital wastewaters have a high load of pharmaceutical active compounds 
(PhACs). Fungal treatments could be appropriate for source treatment of such 
effluents but the transition to non-sterile conditions proved to be difficult due to 
competition with indigenous microorganisms, resulting in very short-duration 
operations. In this article, coagulation-flocculation and UV-radiation processes 
were studied as pretreatments to a fungal reactor treating non-sterile hospital 
wastewater in sequential batch operation and continuous operation modes.The 
influent was spiked with ibuprofen and ketoprofen, and both compounds were 
successfully degraded by over 80%. High concentrations of microorganisms 
seemed to reduce the activity of the fungus and therefore the longevity of the 
treatment. The best strategy was the addition of a coagulation-flocculation 
pretreatment to a continuous reactor, which led to an operation of 28 days 
without biomass renovation.  
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non-sterile, hospital wastewater 
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1. Introduction 
There is a growing concern among regulatory agencies and in the scientific 
community about pharmaceutical active compounds (PhACs) occurring in 
environmental water bodies. Healthcare waste management is imperative but 
hospital wastewater (HWW), with similar pollutant load as urban wastewater but 
much higher concentrations of PhACs, is commonly discharged into public 
sewage systems [1]. HWW constitutes the main source of PhACs in the influent 
of wastewater treatment plants (WWTP), which are not designed to remove 
these pollutants [2,3]. Consequently, these effluents could be a vector to 
introduce PhACs in the environment through wastewater reuse purposes such 
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as irrigation, landscape and surface or groundwater replenishment [4]. 
Therefore, a specific HWW treatment step before the HWW is mixed with urban 
wastewater would prevent PhAC contamination of the WWTP influent. Among 
the potential technologies for removing recalcitrant organic pollutants in 
wastewater, fungal treatment is a particularly promising strategy to biodegrade 
those pollutants due to their unspecific enzymatic systems. Several studies 
have reported the capacity of white rot fungi (and particularly  Trametes 
versicolor) in degrading a wide range of emerging pollutants including PhACs 
[5,6]. These studies have been carried out at different scales, from within 
Erlenmeyer flasks to bench bioreactors, and they have been conducted mainly 
in sterile conditions to best monitor the fungal degradation during the batch 
process. The studied pollutant concentrations are on the order of a few mg·L-1, 
but the typical concentrations in wastewater are on the order of 1 ng·L-1 [7,8]. 
Moreover, the long-term operation of fungal biodegradation processes during a 
continuous fungal treatment of a synthetic textile wastewater, in sterile 
conditions, was demonstrated with a cellular retention time (CRT) of 21 days 
[9]. The biomass was retained in the reactor but periodic partial biomass 
removals were performed to limit the aging of the biomass and consequently to 
guarantee that metabolic activity occurred under growth-limiting conditions. 
However, the partial biomass renovation strategy was not enough to maintain 
fungus viability during the treatment of HWW under non-sterile conditions [8]. 
Few other references can be found that investigate the treatment of non-sterile 
wastewater by fungi in a continuous mode. The non-favorable competition 
between the inoculated fungus and the microorganisms in the real wastewater 
demonstrated the difficulty of developing an efficient treatment on an industrial 
scale due to the relatively short fungal viability time [10–13]. 
A novel strategy to extend the fungal viability period has not yet been 
established and is essential to guarantee the long-term operation for the 
continuous treatment of HWW, which may be achieved through a continuous 
pumping of the influent or by sequential batch reactor (SBR) operation. In both 
strategies the biomass is retained in the bioreactor. In addition, a pretreatment 
for the HWW may reduce the bacteria level in the influent of the fungal 
bioreactor and consequently extend its viability. These processes include 
coagulation-flocculation and UV radiation, both methods widely used in WWTP 
[14,15]. Their technology can be readily applied, but none of the methods have 
been used as pretreatments before. 
Therefore, the main objective of this study is to increase the T. versicolor 
viability inside the reactor during a continuous treatment of non-sterile HWW. To 
achieve this, the following two approaches have been examined: first, the 
addition of two pretreatments, a coagulation-flocculation step and a UV 
irradiation step, and second, the continuous operation of the reactor and a SBR. 
The influence of both strategies on the viability period has been studied. The 
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HWW was spiked with ibuprofen (IBU) and ketoprofen (KETO) for analytical 
purposes. 
2. Materials and methods 
 
2.1. Reagents, fungus and hospital wastewater 
Ketoprofen and ibuprofen were purchased from Sigma-Aldrich (Barcelona, 
Spain). Thiamine hydrochloride was acquired from Merck (Barcelona, Spain), 
peptone and yeast extract from Scharlau (Barcelona, Spain) and glucose, 
ammonium chloride and other chemicals were purchased from Sigma-Aldrich 
(Barcelona, Spain). PhACs were of HPLC purity grade (>99%) and all other 
chemicals used were of analytical grade. 
T. versicolor (ATCC#42530) was maintained on 2% malt agar slants at 25°C 
until use. Subcultures were routinely made. A mycelial suspension of T. 
versicolor was obtained as previously described by Borràs et al. [16]. 
The HWW was collected directly from the sewer manifold of Josep Trueta 
Hospital (Girona, Catalonia) in the NE of Spain. Fresh samples were collected 
prior to every experiment and stored at 4°C. The characteristics of the 
wastewaters are summarized in Table 1. 
2.2. Medium and pellet formation 
Fungal pellets were obtained by inoculating 2.7 mL·L-1 of the mycelial 
suspension in a1.5 L of defined medium in a sterile glass air-pulsed fluidized 
bioreactor. The medium contained per liter: 10 g glucose, 100 mL 
macronutrients, 10 mL micronutrients, 2.1 g NH4Cl and 10 mg thiamine [16].The 
pH was controlled at 4.5 by adding HCl 1 M or NaOH 1 M and the O2 was 
measured to ensure proper aeration. Fluidized conditions in the reactors were 
maintained by using 1 s air pulse every 4 s. The aeration rate was 0.8 L·min-1 
and the temperature was maintained at 25°C. 
2.3. Coagulation-flocculation pretreatment 
The coagulation-flocculation experiments were carried out following ASTM 
D2035-13 guidelines [17] in ajar-test apparatus (Flocculator SW1 from Stuart 
Scientific, Staffordshire, UK). Coagulants HypolDW217 and HyflocAC50 and 
flocculants HimolocJO2030 and HimolocDR3000 were kindly provided by 
Derypol, S.A. (Barcelona, Spain). The jar tests involved 2 min of coagulation at 
200 rpm, 15 min of flocculation at 20 rpm and 30 min of settling. 
2.4. UV-C irradiation pretreatment 
The HWW pretreated by coagulation-flocculation was stored at room 
temperature in a 2 L sterile glass bottle and stirred magnetically. This pretreated 
A ce
pt
 man
uscr
ipt
HWW was then pumped, using a 0.5 L/D flow rate, into a Jebo UV-H9 UV-C 
sterilizer unit (9 W, mercury-arc low pressure lamp, 254 nm wavelength, JEBO, 
United States) with a residence time of 9.6 h. The effluent was collected in a 
sterile bottle until the volume required to fill the bioreactor was reached (1.5 L). 
Samples for the heterotrophic plate count and absorbance measurement at 650 
nm were taken every 24 h. 
2.5. HWW treatments 
After the pellet growth, the medium was withdrawn, and the bioreactor was filled 
with untreated HWW or pretreated HWW, depending on the experiment. Before 
placement in the bioreactor, the influent was spiked with ketoprofen and 
ibuprofen to reach a total concentration of 20 mg·L-1 of each PhAC. Two 
bioreactors were run in parallel, one operating continuously with a hydraulic 
residence time (HRT) of 3 days and the other operating as an SBR with a cycle 
of 3 d. The first experiment used raw HWW2, the second experiment used 
HWW1 with a coagulation-flocculation pretreatment, and the third experiment 
used HWW3 with a coagulation-flocculation process followed by a UV 
irradiation step, as summarized in Fig. 1. 
2.6. PhACs analysis 
Samples were filtered through a Millipore Millex-GV PVDF 0.22 µm membrane 
and placed in amber vials to avoid photodegradation. Analyses were carried out 
using a Dionex Ultimate 3000 HPLC system equipped with a UV detector. The 
separation was achieved on a GraceSmart RP 18 column (250mm x 4.6mm, 
particle size 5µm). The mobile phase consisted of 0.01 M K2HPO4 containing 2 
g·L-1 methane sulphonic acid adjusted to pH 6.5 (Pump A) and acetonitrile 
(Pump B). The flow rate was 1.5 mL·min-1 and the eluent gradient started at 
15% B and increased to 50% from 0 to 15 min; the gradient decreased to 15% 
B from 15 to 16 min and remained at 15% B from 16 to 20 min. A sample 
volume of 20 µL was injected from a Dionex autosampler and the detection was 
carried out at 210 nm. All determinations were performed at 30ºC. 
2.7. Other analyses 
Glucose concentration was measured per triplicate with an YSI 2700 SELECT 
enzymatic analyzer (Yellow Spring Instruments). Laccase activity was 
measured per triplicate using a modified version of the method for the 
determination of manganese peroxidase where 2,6-dimetoxyphenol (DMP) is 
oxidized by laccase in the absence of a cofactor [18]. Changes in the 
absorbance at 468 nm were monitored for 2 min on a Varian Cary 3 UV/Vis 
spectrophotometer at 30ºC. Activity units per liter (U·L−1) are defined as the 
micromoles per liter of DMP oxidized per minute. The molar extinction 
coefficient of DMP was 24.8 mM−1·cm−1 [19].The conductivity was determined 
by a CRISON MicroCM 2100 conductometer, and the absorbance at 650 nm 
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was monitored by a UNICAM 8625 UV/VIS spectrometer. Heterotrophic plate 
count (HPC) was analyzed per triplicate according to APHA (1995) [20]. 
Chloride, sulfate, nitrate and phosphate anions were quantified by a Dionex 
ICS-2000 ionic chromatograph. The total suspended solids (TSS), dissolved 
inorganic carbon (DIC) and dissolved organic carbon (DOC) were determined 
according to APHA (1995) [20]. The N-NH4+ concentration and chemical oxygen 
demand (COD) were analyzed by using commercial kits LCH303 and LCK114 
or LCK314, respectively (Hach Lange, Germany). 
3. Results and discussion 
Three hospital wastewaters, HWW1 through HWW3, were characterized 
physically, chemically and biologically (Table 1). Most of the parameters are in 
the same range as other hospital effluents with the exception of conductivity 
and chloride concentration, which were higher than those reported [3,7]. 
Although their concentrations were not uncommonly high, the COD and TSS 
concentrations in HWW3 were twice that in HWW1 and HWW2, while the 
ammonia concentration was very low. HWW3 also had the highest chloride 
concentration (15,723 mg Cl·L-1). However, HWW1 had the greatest HPC, 
4.3·109 cfu·mL-1, while HWW2 and HWW3 had counts in the 107 cfu·mL-1 range. 
3.1. Study of the pretreatments 
3.1.1. Coagulation-flocculation 
The type and dosage of the coagulants are two of the most important 
parameters to consider when optimizing this process [21]. HypolDW217 and 
HyflocAC50 were evaluated as coagulants at concentrations of 1 – 5 mg·L-1 and 
150 – 300 mg·L-1, respectively, and HimolocJO2030 and HimolocDR3000 were 
evaluated as flocculants at a concentration of 15 – 30 mg·L-1, as recommended 
by the company who provided these products. Table 2 shows the experimental 
design and the obtained results. Coagulant HypolDW217 produced consistently 
low absorbance reductions, independent of the flocculant type and 
concentration used, while coagulant HyflocAC50 achieved zero absorbance 
values with both flocculants and at almost all tested concentrations. 
Consequently, HyflocAC50 is considered as a suitable coagulant for reducing 
the absorbance of HWW. The results were consistent regardless of the 
flocculant used, even when taking into account that HimolocDR3000 is a high 
molecular weight flocculant with medium cationicity and HimolocJO2030 is a 
very high molecular weight flocculant with high anionicity. Experiment 15, 
nonetheless, showed a typical coagulant overdose behavior visible only with 
DR3000 [15,21,22]. This result suggests that the different characteristics of the 
two flocculants did indeed play a distinct role in the coagulation-flocculation 
process. Finally, products HyflocAC50 and HimolocDR3000 were chosen as the 
coagulant and flocculant, respectively. 
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The final concentrations of the coagulant and flocculant had to be adjusted for 
every HWW. Table 3 summarizes the doses used in each pretreatment, while 
Table 1 shows the physical, chemical and biological characterization of the 
three raw and pretreated wastewaters used. In general, pretreated samples 
have similar or lower parameters than the raw wastewaters [23]. The HPC 
reduction achieved after the coagulation-flocculation pretreatment is very 
important, with reductions by factors of 10 to 104. Additionally, a substantial 
reduction in TSS is observed in all 3 cases, although a reduction in COD is only 
observed in 2 out of 3 HWWs tested.  
3.1.2. UV-C irradiation 
UV disinfection is a widely known technology used as a tertiary treatment in 
WWTP as an attractive alternative to chlorination/dechlorination processes 
because it is a chemical-free process, reduces the presence of potential 
chlorinated hydrocarbons and also deactivates chlorine-resistant 
microorganisms [24,25]. However, its use as a pretreatment is much less 
studied. The experiments were planned as preliminary work to determine 
whether UV-C irradiation could be a suitable pretreatment for the bioreactor 
influent. 
Several studies highlight the role of the concentration and size of the 
suspended solids in UV disinfection [25,26]. Particles provide shelter to 
microorganisms against UV by absorbing or reflecting the UV. This can be 
partially overcome by using higher intensities and contact times, although the 
improvement is still limited. Das [24] proposed 5–10 mg·L-1 of TSS as an 
acceptable range in which UV disinfection is effective. The TSS of the raw 
HWW used in the study ranged from 145 – 350 mg·L-1, which is much higher 
than the maximum of that acceptable range and could thus explain the 
ineffectiveness of the UV treatment. However, the flocculated HWWs had a 
TSS level of 30 – 105 mg·L-1, still above the recommended range. 
Nevertheless, a 10 to 100 – fold diminution of HPC was obtained. This may be 
explained by the long contact time used in the experiments. No significant 
reduction in absorbance was found, due to the flocculated HWW having values 
very close to zero. Therefore, UV-C irradiation was applied as a pretreatment 
only after a coagulation-flocculation process. 
3.2. Bioreactor operation 
The testing of both the HWW pretreatment and the operation mode was 
performed to find approaches that increase the duration of Trametes versicolor 
viability in the bioreactor. Although widely used in wastewater and drinking 
water treatment plants, coagulation-flocculation and UV-radiation had not been 
studied as pretreatments for a fungal operation. As summarized in Fig. 1, three 
experiments were conducted with (A) no pretreatment, (B) coagulation-
flocculation pretreatment and (C) coagulation-flocculation followed by a UV-
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radiation pretreatment. In each experiment, two reactors were operated 
simultaneously: one in continuous mode (1) and one in SBR mode (2). As 
reviewed elsewhere, the SBR operation would act as selective disinfection, 
namely, the elimination of undesired microorganisms while retaining the fungal 
biomass [27]. Both continuous and SBR modes had an HRT of 3 d, as the 
processes of pellet settling and liquid phase draining and refilling in the SBR 
took only 15 min and 95% of the liquid could be removed. Glucose and NH4Cl 
were added at their consumption rates to keep the fungus in growth-limiting 
conditions and to prevent COD increases in the effluent. A low carbon-to-
nitrogen ratio of 7.5 was chosen to enhance the fungus survival over the native 
bacteria [28]. 
HPC, laccase activity, and IBU and KETO removal were monitored; the results 
are presented in Fig. 2-4. The operation was stopped after repeated measures 
of the IBU and KETO degradation percentage dropped below 80%. 
3.2.1. Heterotrophic plate count evolution 
Most of the studies found in the literature focus on degradation of selected 
compounds in sterile conditions or non-sterile tap water [6,12,29,30]. However, 
Espinosa-Ortiz et al. (2016) highlighted the necessity of working in non-sterile 
matrices [27]. In real non-sterile hospital wastewater, concentration of 
microorganisms, expressed as HPC, have special importance. Fig. 2 shows the 
HPC results for all the experiments. In experiment A, with no pretreatment, both 
the continuous operation and the SBR exhibited a 100-fold increase in the initial 
concentration of heterotrophs after 3 d of treatment, with an HPC of 
approximately 108 cfu·mL-1 after 6 d operation. Experiment B, with coagulation-
flocculation pretreatment, exhibited a slight increase in the continuous treatment 
during the 27 d of treatment, which leads to a 100-fold HPC increase by the end 
of the process. However, increases by factors of 10-1000 were observed in 
each 3 d SBR cycle. The dramatic change in HPC can be explained by the 
native HHW microorganisms consuming the glucose and NH4Cl added in 
addition to the nutrients in the wastewater itself. The resulting heterotroph 
population could be adhered to the fungal biomass and suspended solids. The 
final HPC was approximately 107 cfu·mL-1 for the continuous treatment and 
approximately 108 cfu·mL-1 for the SBR. In experiment C (Fig. 2C), with a 
coagulation-flocculation pretreatment followed by a UV radiation step, the initial 
concentration of heterotrophic microorganisms was lower than the other two 
experiments (approximately 104 cfu·mL-1); however, a very rapid 1000-fold 
increase was detected within the first 10 days of operation in both treatment 
strategies. This low initial HPC was due to the UV-radiation step, while the fast 
increase could be either due to the regrowth of microorganisms sheltered by 
suspended solids or to growth of resistant bacteria due to decreased 
competition with other bacteria; many of which were eliminated by the UV 
radiation [31]. The HPC increased until it reached a concentration of 108 cfu·mL-
Acc
pted
 man
uscr
ipt
1 in the 10th day of continuous operation but stabilized at approximately 106 
cfu·mL-1. The HPC in the SBR peaked at 109 cfu·mL-1 in the 4th cycle and 
remained at 108 cfu·mL-1 in the last batch. There seems to be a threshold HPC 
of approximately 108 cfu·mL-1, beyond which the operation could not continue, 
regardless of the pretreatment or operation mode. In addition, the continuous 
mode exhibited a consistently lower HPC than that of the SBR mode. 
3.2.2. Laccase activity profile  
Fig. 3 shows the laccase profiles measured in all three experiments. Experiment 
A exhibited a maximum activity (Fig. 3A) of approximately 50 UA·L-1 at Day 4 
for both operation modes. The laccase profile diminished from that day up to 
undetectable levels after 9 d. In experiment B, laccase peaked at the end of the 
first cycle but then dropped significantly after the second cycle (Fig. 3B). In 
subsequent cycles, the laccase production was recovered up to the initial cycle 
level during the 5th cycle; afterward, the laccase activity showed an important 
reduction following each additional cycle. However, low laccase production was 
observed in the continuous reactor. Even when the measured laccase activity 
decreased, it is evident that T. versicolor was able to produce enzymes 
because the laccase profile stayed above the theoretical laccase activity 
assuming zero production, shown as dotted lines in the stages in Fig. 3. Finally, 
in experiment C, the laccase profiles (Fig. 3C) showed a maximum peak at Day 
6 for the continuous treatment or 2nd batch for the SBR. Afterward, the laccase 
production decreased dramatically, and no laccase activity was detected after 
the 4th batch or in the 14th day of continuous operation. It is noteworthy that in 
experiment C, the theoretical laccase activity assuming no production was 
higher than the actual activity in the reactor, indicating deactivation of the 
enzyme. This may be explained as an effect of bacterial competition, which has 
been reported to inhibit fungal enzyme secretion capacity and to inactivate the 
secreted enzyme [32,33]. 
Although laccase can be produced by both fungi and bacteria [34], the control 
experiments with HWW demonstrated that the production of laccase by its 
native bacterial microorganisms was not significant (data not shown). 
Consequently, the laccase production may be confidently linked to fungus 
activity. However, low or nonexistent laccase activity cannot be the sole 
indicator of T. versicolor inactivity. Previous studies have detected the presence 
of the fungus with denaturing gradient gel electrophoresis (DGGE) in 
continuous treatments where laccase activity was very low and HWW could 
inhibit the laccase activity assay [10]. Several other continuous-mode fungal 
water treatment operations have reported very low or no extracellular enzymatic 
activity [12,35].  
3.2.3. Ibuprofen and ketoprofen degradation 
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Ibuprofen and ketoprofen were the PhACs selected to spike the HWW. Both 
pharmaceuticals are among the most widely used anti-inflammatory drugs, and 
both can be degraded by T. versicolor [6,36,37]. 
The results for the rates of IBU and KETO degradation are presented in Fig. 4. 
In experiment A, in the continuous treatment, 90% of ibuprofen was degraded, 
while ketoprofen degradation rates were below 70% after day 5. In the SBR 
mode, both IBU and KETO had degradation rates of 80% and above for the first 
and third batches. The experiment was finally stopped at day 12 when the 
threshold degradation was not reached, and the breakdown of the fungal pellets 
into free mycelium was observed. In experiment B, the elimination rates of both 
pharmaceuticals (Fig. 4B) stayed above 80% for the majority of the continuous 
operation. During the SBR operation, KETO degradation was approximately 
90% during the first 5 cycles but decreased significantly thereafter. However, 
IBU was completely degraded during 7 cycles and only was detected in the last 
cycle. Both reactors were operated for 28 days until the degradation rates fell 
below 80%. Other signals of low fungal activity were also observed, including 
low laccase production and the loss of original biomass pellet shape. In 
experiment C, the degradation of IBU remained constant at 78% during the first 
14 days of continuous treatment but then increased up to 95%. KETO 
degradation, however, was higher than 80% until Day 11 when it quickly 
dropped to degradation rates lower than 40%. During SBR operation, KETO 
degradation was higher than 80% during all cycles, but the removal of KETO 
removal was high only in the three first cycles. At the end of fourth cycle, the 
degradation was minimal although it recovered to approximately 65% in the fifth 
cycle, when the experiment was stopped due to low fungal activity. Few 
references can be found regarding IBU and KETO removal in wastewaters. 
Badia-Fabregat et al. (2015) reported a 67% and 46% removal of IBU and 
KETO, respectively in sterile non-spiked urban wastewater, lower than the 80% 
threshold used in the present manuscript [8]. However, Nguyen et al. (2013) 
reported a very high 90% removal of ketoprofen in a fungus-augmented 
membrane bioreactor, although in sterile conditions [30]. 
The results of experiments A and B indicated that ibuprofen was eliminated 
faster than ketoprofen during long-term operation in both continuous and SBR 
strategies, although the results of experiment C are slightly different. These 
results agree with previous reports [5,8]. The pathway of fungal degradation of 
IBU remains unknown, but it does not involve laccase. This result is in 
agreement with the present results, as IBU was removed when no laccase 
activity was detected. This pathway does not involve the cytochrome P450 
system either. The UV pretreatment seemed to decrease the removal of IBU 
during the early reactor operation, which is possibly related to its distinct 
degradation pathway. Ketoprofen was eliminated in both reactors; this is 
consistent with previous reports, which state that KETO is degraded by T. 
Acce
pt d
 man
uscr
ipt
versicolor, with the P450 system involved in the degradation and the laccase 
system playing only a minor role [37]. As a result, ketoprofen was degraded 
even when no laccase activity was detected in the bioreactor. To conclude, IBU 
and KETO have been effectively eliminated in both reactors when treating non-
sterile HWW with long-duration treatments. 
Experiment B, which used a coagulation-flocculation pretreatment before the 
fungal reactor, was selected as the best strategy because it exhibited the 
longest viability period of 28 d. This viability period could be further extended by 
implementing a partial biomass renovation strategy to overcome the biomass 
aging process. The sequential batch reactor operations showed better IBU and 
KETO reductions than continuous operations in experiments A and C but not in 
experiment B, where the continuous operation maintained elimination between 
70 – 90% for a long period of time. As a result, a second step in the 
pretreatment of HWW effluent did not improve the fungal bioreactor. In addition, 
the use of the continuous operation mode was chosen as the best strategy for 
long-term fungal degradation with fungal biomass retained in the bioreactor. 
This strategy has operational advantages, such as requiring less labor because 
it is easy to automate. To the best of our knowledge, this is the first time that an 
air-pulsed fungal reactor without biomass renovation treated non-sterile HWW 
with high elimination yields for 28 days. 
4. Conclusions 
Pretreating HWW with a coagulation-flocculation process can reduce the initial 
HPC level up to 104 cfu·mL-1, which extended the fungal viability during the 
continuous treatment of a non-sterile real effluent. The addition of a UV 
pretreatment did not lead to better performance of the fungal bioreactor in terms 
of higher PhAC reductions or longer operation time. Testing of the operation 
modes indicated that continuous operation is preferred over SBR because the 
reduction capacity of T. versicolor was maintained for a longer period. The 
optimal treatment setup, a coagulation-flocculation pretreatment coupled to a 
fungal treatment in an air-pulsed fluidized bioreactor with retained biomass in 
pellet form, maintained fungal activity for 28 days without purging or biomass 
renovation. Consequently, a length of operation similar to the operation in sterile 
conditions was achieved. Future work should consider partial biomass 
renovation to further extend the viable duration of fungal degradation and to 
overcome the biomass aging process, which are essential requirements to 
guarantee longer-term continuous HWW treatment. 
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 Fig. 1. Bioreactors experiments diagram. A, B and C are the experiment ID; 1 and 2 represent continuous 
operation and sequential batch reactor operation, respectively. Dark grey rectangles represent the initial 
wastewater; light grey rectangles, the pretreatment steps; white rectangles, the mode of operation.  
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 Fig. 2. Heterotrophic plate count profile in the reactors with no pretreatment (A); with a flocculation step 
(B); with a flocculation and a UV-radiation step (C). Legend: black bars represent the initial concentration 
in the SBR treatment; white bars, the final concentration in the SBR treatment; white circles, the 
concentration profile in the continuous treatment. 
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 Fig. 3. Laccase activity profile in the reactors with no pretreatment (A); with a flocculation step (B); with a 
flocculation and a UV-radiation step (C). Legend: white bars represent the final concentration in the SBR 
treatment; black circles, the activity profile in the continuous treatment; dotted lines represent the 
theoretical concentration of laccase if no generation is assumed.  
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 Fig. 4. Elimination profile of ketoprofen and ibuprofen in the reactors with no pretreatment (A); with a 
flocculation step (B); with a flocculation and a UV-radiation step (C). Legend: black bars and white bars 
represent the ketoprofen and ibuprofen degradation, respectively, in the SBR; gray squares and gray 
circles represent the ketoprofen and ibuprofen degradation, respectively, in the continuous treatment.  
A 
C 
B 
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Table 1.Physical, chemical and biological characterization of hospital wastewater. 
Sampling date
Experiment
Raw Flocculated Raw Flocculated Raw Flocculated Flocculated & UV
pH 6.84 8.12 7.07 7.08 7.2 7.3 7.93
Conductivity (mS·cm -1) 1.23 1.16 1.72 1.82 4.69 4.76 4.46
Absorbance at 650 nm 0.189 0,000 0.154 0.012 0.353 0.006 0.009
HPC (cfu·mL-1) 4.3·109  ± 3.5·108 7.5·105  ± 2.2·105 7.4·107 ± 1.7·107 5.4·104 ± 7.0·103 1.9·107 ± 6.1·106 1.8·106 ± 5.2·105 4.0·105 ± 2.9·105
Chloride (mg Cl·L-1) 1603,8 1810,6 1874,0 2073,4 15723,7 16125,9 15372,9
Sulfate (mg S·L-1) 31,6 25,6 42,0 37,5 19,8 25,9 23,4
Nitrate (mg N·L-1) 170,6 190,1 239,9 223,6 236,7 287,3 282,8
Phosphate (mg P·L-1) 0,2 0,5 0,1 0,1 0,7 0,0 0,2
Ammonia (mg N · L-1) 15,5 8,0 24,4 8,5 0,2 1,8 0,1
TSS (mg·L-1) 150 30 145 55 350 105 55
COD (mg O2·L-1) 343 ± 13 108 ± 4 293 ± 15 297 ± 1 614 ± 20 313 ± 2 44 ± 3
DIC (mg·L-1) 77 ± 3 63 ± 3 117 ± 3 95 ± 1 76 ± 3 73 ± 2 80 ± 2
DOC (mg·L-1) 49 ± 7 47 ± 3 56 ± 3 87 ± 2 99 ± 9 90 ± 6 21 ± 4
22/01/2015 04/03/2015 12/06/2015
HWW1 HWW2 HWW3
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Table 2.Absorbance reduction of different coagulant-flocculant mixtures. Absorbance of the initial raw wastewater was 0.189. 
Experiment ID
Final 
absorbance
at 650 nm
1 Hypol DW217 1 Himoloc JO2030 15 0,155
2 1 30 0,174
3 5 15 0,144
4 5 30 0,141
5 Hyfloc AC50 150 Himoloc JO2030 15 0,008
6 150 30 0,000
7 300 15 0,000
8 300 30 0,000
9 Hypol DW217 1 Himoloc DR3000 15 0,145
10 1 30 0,133
11 5 15 0,078
12 5 30 0,131
13 Hyfloc AC50 150 Himoloc DR3000 15 0,000
14 150 30 0,000
15 300 15 0,129
16 300 30 0,000
Flocculant
concentration (mg·L-1)
Coagulant
concentration (mg·L-1)
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Table 3. Coagulant – flocculant doses used in the different HWW. 
HWW
1
2
3
Coagulant
concentration (mg·L-1)
Flocculant
concentration (mg·L-1)
4,537
95 11
15150
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